Elise Marechal

Elise Marechal

Auto-generated profile, based on publicly available information

Elise Marechal

MMG, INSERM, Aix-Marseille Univ

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
DADaniel Aldea
Daniel Aldea
NMNicolas Macagno
Nicolas Macagno
EMElise Marechal
Elise Marechal
MMMathias Moreno
Mathias Moreno
PRPauline Romanet
Pauline Romanet
Heather EtcheversHeather Etchevers
Heather Etchevers

25 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
EMElise Marechal
Elise Marechal
DADaniel Aldea
Daniel Aldea
PQPatrice Quintana
Patrice Quintana
GMGrégoire Mondielli
Grégoire Mondielli
NBNathalie Bernard-Marissal
Nathalie Bernard-Marissal
Heather EtcheversHeather Etchevers
Heather Etchevers
RASopathies, rare congenital syndromes affecting multiple organ systems, often include peripheral neuropathy of unknown origin. While RASopathy-associated gene variants are proto-oncogenic, the impact of timing and mosaicism on pathogenicity remains poorly understood. Here, we investigate the links between Braf, a key mitogen-activated protein kinase (MAPK) effector, and peripheral neuropathy. By targeting Braf p.V600E, an oncogenic variant found in mosaic RASopathies, to embryonic Mpz-expressing cells in mice, we induced a congenital Charcot-Marie-Tooth-like degenerative neuropathy. This phenotype was characterized by hyperplastic nerves, hindlimb weakness, and unexpectedly reduced body size. Constitutively active Braf expanded a Jun+ Schwann cell repair state, impairing myelination and nerve homeostasis. To examine relevance to RASopathies, we differentiated patient-derived stem cells bearing the cardio-facio-cutaneous syndrome-associated BRAF p.Q257R variant into Schwann cells. Compared to wild-type controls, CFC-derived cells failed to acquire mature phenotypes, instead exhibiting progenitor or repair-type transcriptional profiles. Our findings implicate somatic mosaicism in the unresolved genetic heterogeneity of neuropathies and expand the candidate gene list for peripheral nerve disorders. Moreover, they reveal a MAPK-dependent mechanism linking neural crest-derived Schwann cell dysfunction to both body growth and nerve homeostasis, providing new insights into the mechanisms in RASopathy-associated neuropathy and potential therapeutic targets.

14 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
DADaniel Aldea
Daniel Aldea
NMNicolas Macagno
Nicolas Macagno
EMElise Marechal
Elise Marechal
MMMathias Moreno
Mathias Moreno
PRPauline Romanet
Pauline Romanet
Heather EtcheversHeather Etchevers
Heather Etchevers
SUMMARY: Congenital melanocytic nevi (CMN) and common acquired melanocytic nevi (AMN) are melanoma-predisposing skin conditions presenting excessive numbers of melanocytes but arising at different times in life. Appropriately weighted whole-genome methylation analysis can be used as a basis for further research in dermatopathology and as applied here provides new insights into nevus biology.

6 April 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
EMElise Marechal
Elise Marechal
APAnne Poliard
Anne Poliard
KHKilian Henry
Kilian Henry
MMMathias Moreno
Mathias Moreno
MLMathilde Legrix
Mathilde Legrix
Heather EtcheversHeather Etchevers
Heather Etchevers
Recurrent missense mutations of the PIK3CA oncogene are among the most frequent drivers of human cancers. These often lead to constitutive activation of its product p110α, a phosphatidylinositol 3-kinase (PI3K) catalytic subunit. In addition to causing a broad range of cancers, the H1047R mutation is also found in affected tissues of a distinct set of congenital tumors and malformations. Collectively termed PIK3CA -related disorders (PRDs), these lead to overgrowth of brain, adipose, connective and musculoskeletal tissues and/or blood and lymphatic vessel components. Vascular malformations are frequently observed in PRD, due to cell-autonomous activation of PI3K signaling within endothelial cells. These, like most muscle, connective tissue and bone, are derived from the embryonic mesoderm. However, important organ systems affected in PRDs are neuroectodermal derivatives. To further examine their development, we drove the most common post-zygotic activating mutation of Pik3ca in neural crest and related embryonic lineages. Outcomes included macrocephaly, cleft secondary palate and more subtle skull anomalies. Surprisingly, Pik3ca -mutant subpopulations of neural crest origin were also associated with widespread cephalic vascular anomalies. Mesectodermal neural crest is a major source of non-endothelial connective tissue in the head, but not the body. To examine the response of vascular connective tissues of the body to constitutive Pik3ca activity during development, we expressed the mutation by way of an Egr2 (Krox20) Cre driver. Lineage tracing led us to observe new lineages that had normally once expressed Krox20 and that may be co-opted in pathogenesis, including vascular pericytes and perimysial fibroblasts. Finally, Schwann cell precursors having transcribed either Krox20 or Sox10 and induced to express constitutively active PI3K were associated with vascular and other tumors. These murine phenotypes may aid discovery of new candidate human PRDs affecting craniofacial and vascular smooth muscle development as well as the reciprocal paracrine signaling mechanisms leading to tissue overgrowth.